Efficacy and Safety of Omalizumab Treatment Over a 16-Year Follow-Up: When a Clinical Trial Meets Real-Life

Francesco Menzella,1 Matteo Fontana,1 Marco Contoli,2 Patrizia Ruggiero,1 Carla Galeone,1 Silvia Capobelli,1 Anna Simonazzi,1 Chiara Catellani,1 Chiara Scelfo,1 Claudia Castagnetti,1 Francesco Livrieri,1 Nicola Facciolongo1 1Pulmonology Unit, Arcispedale Santa Maria Nuova, Azienda USL – IRCCS di Reg...

Cijeli opis

Bibliografski detalji

Glavni autori:	Menzella F, Fontana M, Contoli M, Ruggiero P, Galeone C, Capobelli S, Simonazzi A, Catellani C, Scelfo C, Castagnetti C, Livrieri F, Facciolongo N
Format:	Artigo
Jezik:	Inglês
Izdano:	Dove Medical Press 2022-04-01
Serija:	Journal of Asthma and Allergy
Teme:	severe allergic asthma biologics omalizumab exacerbations side effects oral corticosteroids
Online pristup:	https://www.dovepress.com/efficacy-and-safety-of-omalizumab-treatment-over-a-16-year-follow-up-w-peer-reviewed-fulltext-article-JAA
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!